Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial.
Saved in:
| Title: | Response adaptive salvage with KTd and ASCT for functional high‐risk multiple myeloma—The Australasian Leukemia and Lymphoma Group (ALLG) MM17 Trial. |
|---|---|
| Authors: | Turner, R.1 (AUTHOR), Quach, H.2,3 (AUTHOR), Horvath, N.4 (AUTHOR), Kerridge, I.5 (AUTHOR), Lee, E.6 (AUTHOR), Morris, E.7 (AUTHOR), Kalff, A.1 (AUTHOR), Khong, T.1 (AUTHOR), Reynolds, J.1,8 (AUTHOR), Spencer, A.1,8 (AUTHOR) andrew.spencer@monash.edu |
| Source: | British Journal of Haematology. Aug2023, Vol. 202 Issue 3, p530-538. 9p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00071048 |
|---|---|
| DOI: | 10.1111/bjh.18914 |